Dr Bradlee Heckmann and his team at the USF Health Neuroscience Institute in the US aim to develop new therapeutic avenues for treating neuroinflammatory and neurodegenerative diseases, including Alzheimer’s.

Read their original article here: http://doi.org/10.4103/1673-5374.317958

Read more about their work in Research Features